Literature DB >> 22094931

Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.

Woo Dae Kang1, Ho Sun Choi, Seok Mo Kim.   

Abstract

OBJECTIVE: The aim of this study was to determine whether or not the serum human chorionic gonadotropin (hCG) level and ratio during 2 weeks after evacuation is predictive of persistent gestational trophoblastic neoplasia (GTN) in patients with complete molar pregnancies.
METHODS: Between January 2000 and June 2010, a total of 467 patients with complete molar pregnancies were diagnosed. Seventeen patients, who had prophylactic chemotherapy and in whom insufficient data were available, were excluded. A receiver operating characteristic curve was used to determine the most useful predictive factor for persistent GTN and multivariate logistic regression was used for analyses.
RESULTS: Persistent GTN was diagnosed in 109 of the 450 patients (24.2%) on the basis of the 2000 FIGO criteria. The optimal cut-off point for hCG 1 and 2 weeks after evacuation was 6400 mIU/mL (sensitivity, 54.1%; specificity, 65.1%) and 2400 mIU/mL (sensitivity, 64.2%; specificity, 78.3%), respectively. The optimal cut-off point for the ratio of pre-evacuation hCG to hCG 2 weeks after evacuation was 30 (sensitivity, 63.3%; specificity, 86.5%). Based on multivariate analysis, this ratio<30 was an independent predictive factor for persistent GTN (odds ratio=6.885; 95% confidence interval, 4.006-11.832; P<0.001).
CONCLUSIONS: The decline ratio in hCG level 2 weeks after evacuation in patients with complete molar pregnancies is the most reliable predictor of persistent GTN. Our analysis may allow clinicians to stratify risk in patients with complete molar pregnancies and to provide more accurate counseling based on the hCG levels obtained 2 weeks after evacuation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094931     DOI: 10.1016/j.ygyno.2011.10.035

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study.

Authors:  Giampiero Capobianco; Elettra Tinacci; Laura Saderi; Francesco Dessole; Marco Petrillo; Massimo Madonia; Giuseppe Virdis; Alessandro Olivari; Davide Adriano Santeufemia; Antonio Cossu; Salvatore Dessole; Giovanni Sotgiu; Pier Luigi Cherchi
Journal:  Front Oncol       Date:  2021-05-05       Impact factor: 6.244

2.  Human chorionic gonadotrophin as an indicator of persistent gestational trophoblastic neoplasia.

Authors:  Soheila Aminimoghaddam; Fariba Yarandi; Forough Nejadsalami; Farrokh Taftachi; Fereshteh Noor Bakhsh; Fatemeh Mahmoudzadeh
Journal:  Med J Islam Repub Iran       Date:  2014-06-11

3.  The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.

Authors:  Eiko Yamamoto; Tien Dat Trinh; Yoko Sekiya; Koji Tamakoshi; Xuan Phuoc Nguyen; Kimihiro Nishino; Kaoru Niimi; Tomomi Kotani; Hiroaki Kajiyama; Kiyosumi Shibata; Quang Thanh Le; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

4.  Early Detection of Gestational Trophoblastic Neoplasia Based on Serial Measurement of Human Chorionic Gonadotrophin Hormone in Women with Molar Pregnancy.

Authors:  Roya Riahi; Abbas Rahimiforoushani; Keramat Nourijelyani; Nooshin Akbari Sharak; Mahmood Bakhtiyari
Journal:  Int J Prev Med       Date:  2020-12-11

5.  Triploidy--Observations in 154 Diandric Cases.

Authors:  Nanna Brink Scholz; Lars Bolund; Mette Nyegaard; Louise Faaborg; Mette Warming Jørgensen; Helle Lund; Isa Niemann; Lone Sunde
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

6.  Does Postevacuation β -Human Chorionic Gonadotropin Level Predict the Persistent Gestational Trophoblastic Neoplasia?

Authors:  Azam Sadat Mousavi; Samieh Karimi; Mitra Modarres Gilani; Setareh Akhavan; Elahe Rezayof
Journal:  ISRN Obstet Gynecol       Date:  2014-03-24

7.  Fatal Cases of Gestational Trophoblastic Neoplasia in a National Trophoblastic Disease Reference Center in Dakar Senegal.

Authors:  Mamour Gueye; Mame Diarra Ndiaye-Gueye; Serigne Modou Kane Gueye; Jean Charles Moreau
Journal:  Int J MCH AIDS       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.